Menopause Treatment Market 2022 Size, Business Statistics, Trends, and Top Companies Detailed Analysis by Forecast to 2028

Published Date : Nov 2022
Author : Pratibha Bhattacharjee
Biography : Sr. content writer at Brand Essence Market Research. Passionate about content curation in the market research vertical. Always striving to create reliable and engaging industry-based content.

Top 5 Menopause Treatment Market Companies in Global Market 2022

The global Menopause Treatment Market is valued at USD 16.49 billion in 2021 and is expected to reach USD 25.62 billion by 2028 with a CAGR- 6.5% over the forecast period.

Global Menopause Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2028. Changing lifestyles and increasing awareness among middle-aged women are key driving factors for the growth of the Global Menopause Treatment Market.

Menopause is a natural process that marks the end of menstrual cycles and it is also known as Climacteric. It can also be associated with a decrease in estrogen and progesterone levels. The typical age for experiencing menopause is 45 – 55 years and varies individually. Some women will find it difficult while going through this stage; symptoms include weight gain, hot flashes, and vaginal dryness. These symptoms continue for around 4 years after the last period and 12 years for around 10% of women. Menopause requires treatment for relieving the signs and preventing the chronic conditions related to it or occurring due to aging. To curb these symptoms, there is a growing demand for medication and technology which can be the key benefits in the menopause treatment market.

Top 5 Menopause Treatment MarketCompanies in Global Market 2022

  1. Pfizer


Pfizer was founded in 1849 by Charles Pfizer and Charles F. Erhart, two cousins who had immigrated to the United States from Ludwigsburg, Germany, the year before. The business produced chemical compounds and was headquartered on Bartlett Street in Williamsburgh, New York where they produced an antiparasitic called santonin. This was an immediate success, although it was the production of citric acid that led to Pfizer's growth in the 1880s. Pfizer continued to buy property in the area (by now the Williamsburg district of the city of Brooklyn, New York, and beginning in 1898, the City of Greater New York) to expand its lab and factory, retaining offices on Flushing Avenue until the 1960s; the Brooklyn plant ultimately closed in 2009.


The Pfizer Company had nearly 79K Employees and had revenue of USD 81.3 bn.

  1. Cipla


In 1935, Cipla was founded by Khwaja Abdul Hamied as 'The Chemical, Industrial & Pharmaceutical Laboratories' in Mumbai. In July 1984, the name of the company was changed to 'Cipla Limited.

In 1985, the US FDA approved the company's bulk drug against HIV and other drugs to treat poor people in the developing world. Led by the founder's son Yusuf Hamied, a Cambridge-educated chemist, the company provided generic AIDS and other drugs to treat poor people in the developing world. In 1995, Cipla launched Deferiprone, the world's first oral iron chelator. In 2001, Cipla offered antiretrovirals for HIV treatment at a fractional cost (less than $350 per year per patient).


The Cipla. The company had nearly 34K Employees and had revenue of USD 2.7 billion.

  1. Novartis


In March 1996, the companies Ciba-Geigy and Sandoz merged to form Novartis; the pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. Other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta in partnership with AstraZeneca, which also divested its agrochemical business. It is one of the largest pharmaceutical companies in the world.


The Novartis Company had nearly 110K Employees and had revenue of USD 51.63 billion.

  1. Novo Nordisk

Novo Nordisk

Novo Nordisk employs more than 48,000 people globally and markets its products in 168 countries. The corporation was created in 1989 through a merger of two Danish companies which date back to the 1920s. The Novo Nordisk logo is the Apis bull, one of the sacred animals of ancient Egypt.

The company was ranked 25th among the 100 Best Companies to Work For in 2010 and 72nd in 2014 by Fortune. In January 2012, Novo Nordisk was named the most sustainable company in the world by the business magazine Corporate Knights while spin-off company Novozymes was named fourth.


The Novo Nordisk Company had nearly 48K Employees and had revenue of USD 140.8 billion.

  1. Merck


Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. It is named after the Merck family, which set up the Merck Group in Germany in 1668. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada.


Merck & Co. was established as an American affiliate in 1891. Merck develops and produces medicines, vaccines, biological therapies, and animal health products. It has multiple blockbuster drugs or products each with 2020 revenues including cancer immunotherapy, anti-diabetic medication, and vaccines against HPV and chickenpox.


The Merck Company had nearly 68K employees and had revenue of USD 48.70 billion.

Key Benefits for Menopause Treatment Market Report:

  • Global Menopause Treatment Market report covers in-depth historical and forecast analysis.
  • Global Menopause Treatment Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, and Regional and Country Level.
  • Global Menopause Treatment Market report helps to identify opportunities in the marketplace.
  • Global Menopause Treatment Market report covers an extensive analysis of emerging trends and the competitive landscape. 


We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us



BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX




1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®